MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-03-0006019
Proderna Biotech Private Limited - chemicals and materials in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹8.05 Cr
▲ 24% YoY
Net profit · FY 2025
₹2.52 Cr
Net margin 31.3%
EBITDA · FY 2025
₹3.04 Cr
EBITDA margin 37.8%
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹1.36 Cr
Issued & subscribed
Satisfied charges
₹50 Lakh
No open charges
Company age
20 yrs
Est. 2006
Directors on board
3
As per MCA filings
About Proderna Biotech Private Limited
Data last updated:
Proderna Biotech Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the aromatics and benzene derivatives segment of the chemicals and materials sector. It was incorporated on 04 December 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2006PTC156177. Its GSTIN is 08AAECP0922H1ZM (Rajasthan).
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.36 Cr. It is led by directors including Deepak Soota and Arun Mittal.
Its last annual general meeting (AGM) was held on 30 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S – 279 GF Greater Kailash 2, New Delhi, Delhi, India – 110048.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.05 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹2.52 Cr (net margin 31.3%) and EBITDA of ₹3.04 Cr (EBITDA margin 37.8%). Revenue has grown at a compounded annual rate (CAGR) of 954% over three years and 8% over five years.
The company is associated with 1 brand: Proderna. As per MCA filings, the company has satisfied charges of ₹50 Lakh on record.
Proderna Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0006019). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website proderna.com.
Company details
CIN U74999DL2006PTC156177
Registration Number 156177
Incorporation Date 04 December 2006
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-03-0006019
Recognitions & Rankings of Proderna Biotech
Contact details
Proderna Biotech Private Limited's registered office is in New Delhi, Delhi. Its website is proderna.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressS – 279 GF Greater Kailash 2, New Delhi, Delhi, India – 110048
- IndustryChemicals and Materials, Aromatics & Benzene Derivatives
To see the full contact details of Proderna Biotech Private Limited, buy the company report.
Comprehensive company report
Proderna Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Proderna Biotech operates one associated brand: Proderna. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Supercritical extraction of spices, herbs, and oil seeds for nutraceuticals and food sectors. | proderna.com |
Business activity
The main business activity of Proderna Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Proderna Biotech Private Limited, buy the company report.
Financials of Proderna Biotech Private Limited
FY 2025 filings availableProderna Biotech Private Limited reported revenue of ₹8.05 Cr (up 24% YoY) for FY 2025.
Revenue · FY 2025
₹8.05 Cr ▲ 24%
Net profit · FY 2025
₹2.52 Cr margin 31.3%
EBITDA · FY 2025
₹3.04 Cr margin 37.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 954%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▲ 67%
5 years · compounded
▲ 19%
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 24% growth in the latest year. EBITDA rose 67% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.04 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.52 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 37.8% | ||||
| Net Profit Margin | 31.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Proderna Biotech Private Limited, buy the company report.
Board of directors of Proderna Biotech Private Limited
Proderna Biotech has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Soota | Director | 04 Dec 2006 | 19 Years 11 Months | Current |
| Arun Mittal Also directs: Chemcaps Limited | Director | 04 Dec 2006 | 19 Years 11 Months | Current |
| Prem Chand Goel Also directs: Chemcaps Limited, Saurabh Textiles Pvt Ltd, Sovereign Autotech Private Limited and 1 more | Director | 04 Dec 2006 | 19 Years 11 Months | Current |
Auditor
Proderna Biotech Private Limited is audited by ALOK MITTAL & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ALOK MITTAL & ASSOCIATES | FY 2023 | 005717N |
Shareholding
The shareholding of Proderna Biotech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Proderna Biotech Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹50 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Oct 2008 | 10127782 | Canara Bank | ₹25 Lakh | Satisfied | |
| 13 Oct 2008 | 10127783 | Canara Bank | ₹25 Lakh | Satisfied |
To see the full charge records of Proderna Biotech Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Proderna Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Proderna Biotech Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 3 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| Minoti Containers |
To see the full MSME payment records of Proderna Biotech Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Proderna Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAECP0922H1ZM | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Proderna Biotech Private Limited, buy the company report.
Recent activity
Proderna Biotech Private Limited has 6 board changes on record since 2006: 3 appointments and 3 cessations. The latest: Paulus Antonius Marcus Stoffels ceased to be Director on 04 Jan 2019.
AGM
Proderna Biotech Private Limited last Annual general meeting of members was held on 30 Aug 2025 as per latest MCA records.
Filing
Proderna Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge registered on 13 Oct 2008 via Charge ID 10127782 with Canara Bank was fully satisfied on 12 Aug 2020.
Charges
A charge registered on 13 Oct 2008 via Charge ID 10127783 with Canara Bank was fully satisfied on 12 Aug 2020.
Ceased
Paulus Antonius Marcus Stoffels ceased to be Director.
Ceased
Christof Kersch ceased to be Director.
Ceased
Geert Feye Woerlee ceased to be Director.
Charges
A charge with Canara Bank amounted to Rs. 0.25 Cr with Charge ID 10127782 was registered on 13 Oct 2008.
Charges
A charge with Canara Bank amounted to Rs. 0.25 Cr with Charge ID 10127783 was registered on 13 Oct 2008.
Appointed
Arun Mittal was appointed as Director.
Appointed
Deepak Soota was appointed as Director.
Appointed
Prem Chand Goel was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Proderna Biotech is an active private limited company based in New Delhi, Delhi, India. The company works in aromatics and benzene derivatives, within the chemicals and materials industry. It was incorporated on 04 December 2006 (20+ years old) and is registered under CIN U74999DL2006PTC156177.
Proderna Biotech has 3 current directors:
- Deepak Soota - Director
- Arun Mittal - Director
- Prem Chand Goel - Director
The latest financial statements of Proderna Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Proderna Biotech is 08AAECP0922H1ZM, registered in Rajasthan.
The CIN (Corporate Identification Number) of Proderna Biotech is U74999DL2006PTC156177. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Proderna Biotech was incorporated on 04 December 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.
Paulus Antonius Marcus Stoffels ceased to be Director on 04 Jan 2019. Christof Kersch ceased to be Director on 17 Dec 2018. Geert Feye Woerlee ceased to be Director on 17 Dec 2018. Proderna Biotech has 6 board changes on record in total.
Yes, Proderna Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0006019).
Proderna Biotech has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 3 overdue payments to 3 micro and small suppliers. The latest return was filed on 30 May 2019.
Proderna Biotech can be reached through the website proderna.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Proderna Biotech is at S – 279 GF Greater Kailash 2, New Delhi, Delhi, India – 110048.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages